Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Event Free Survival (EFS) Irrespective of Hematopoietic Cell Transplantation (HCT) Conditioning Regimen, Graft Αβ T and B-Cell Depletion or Patient Weight Category in Children with Acute Lymphoblastic Leukemia (ALL)

Bibliographic Details
Title:	Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Event Free Survival (EFS) Irrespective of Hematopoietic Cell Transplantation (HCT) Conditioning Regimen, Graft Αβ T and B-Cell Depletion or Patient Weight Category in Children with Acute Lymphoblastic Leukemia (ALL)
Authors:	Abdel-Azim, Hisham, Dvorak, Christopher C., Bunin, Nancy, Walters, Mark C., Talano, Julie-An M., Anderson, Eric Jon, Malvar, Jemily, Chaudhury, Sonali, Cairo, Mitchell S., Kitko, Carrie Lynn, Monos, Dimitri S., Wing, Leung, Pulsipher, Michael A.
Source:	Biology of blood and marrow transplantation. 26(S):S90-S92
Availability:	http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100100240018.0x000001&indx=1&recIds=ETOCvdc_100100240018.0x000001
Database:	British Library Document Supply Centre Inside Serials & Conference Proceedings

More Details
ISSN:	10838791
Published in:	Biology of blood and marrow transplantation
Language:	English